SCHEMBL13704166

SCHEMBL13704166

CC(C(=O)Nc1ccccc1)c1ccc(-c2ccccc2)c(F)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 1.00
SMN1; SMN2 Q16637 4/20 1.00
MAPT P10636 3/20 1.00
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
HTT P42858 2/20 0.86
CA12 O43570 2/20 0.77
CA1 P00915 2/20 0.77
CA2 P00918 2/20 0.77
CA4 P22748 2/20 0.77
CA9 Q16790 2/20 0.77
NPSR1 Q6W5P4 2/20 0.73
PTGS1 P23219 4/20 0.70
AKR1C3 P42330 4/20 0.70
AKR1C2 P52895 4/20 0.70
PTGS2 P35354 3/20 0.70
FABP2 P12104 1/20 0.70
TSHR P16473 1/20 0.70
AKR1C4 P17516 1/20 0.70
ADRA2B P18089 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28669346 0.92 LMNA (0.86) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5350115 0.91 LMNA (0.84) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5350109 0.91 LMNA (0.84) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5325984 0.90 LMNA (0.82) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL13704192 0.90 LMNA (0.82) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5325980 0.90 LMNA (0.82) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL28689425 0.89 LMNA (0.80) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5321570 0.89 LMNA (0.80) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5321562 0.89 LMNA (0.80) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL30536489 0.89 LMNA (0.80) LMNASMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585997-B2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof CHESTERFORD ENTERPRISES LIMITED (KY) 2009-09-08 US disclosed
US-7585997-B2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof CHESTERFORD ENTERPRISES LIMITED (KY) 2009-09-08 US disclosed